Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. provided earnings guidance for the 31 December 2013. The board of directors of the company reported the shareholders of the company and potential investors that, the company and its subsidiaries are expected to record a substantial increase in profits for the year ended 31 December 2013 as compared to the year ended 31 December 2012.

Such increase in profits is mainly attributable to the significant increase in the company's sales during such period.